Events
Benzinga Professional
- 01:51 PM UPDATE: Piper Jaffray Raises PT on Actavis on Pro Forma Estimates
- 1:50 PM Cell Therapeutics Spikes Higher; May be Attributed to UBS Conference Presentation
- 01:49 PM UPDATE: Goldman Sachs Raises PT on Steve Madden on Potential Capital Allocation Outcomes
- 01:47 PM UPDATE: Piper Jaffray Raises PT on Zynga on New Game Traction
- 01:39 PM UPDATE: Morgan Stanley Lowers PT on CNInsure on Short-term Margin
- 1:37 PM Onyxx Pharmaceuticals Moves Lower, May be Attributed to Cautious Comments Out of Bank of America
- 01:35 PM UPDATE: RS Platou Lowers PT on Carnival on Reduced Company Guidance
- 1:35 PM Clearwire Special Meeting of Holders Rescheduled for May 31st
- 01:32 PM UPDATE: Piper Jaffray Raises PT on 3D Systems
- 1:30 PM EA Starting New Strategic Partnership with Microsoft
- 01:28 PM UPDATE: Wedbush Raises PT on Polaris on Market Share Gains in North America
- 01:26 PM UPDATE: BGC Partners Initiates Coverage on Linkedin
- 1:24 PM JP Morgan Maintains Neutral on Camden Property Trust, Raises PT to $76.00
- 1:21 PM Jefferies Maintains Hold on BancorpSouth, Inc., Raises PT to $16.00
- 01:19 PM UPDATE: J.P. Morgan Raises PT on hhgregg on Improved Traffic
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- UPDATE: Wedbush Raises PT on Polaris on Market Share Gains in North America
- UPDATE: BGC Partners Initiates Coverage on Linkedin
- UPDATE: J.P. Morgan Raises PT on hhgregg on Improved Traffic
- Merchants Bank Announces Promotion of Geoffrey Hesslink to Chief Operating Officer
- Mid-Day Market Update: Navios Maritime Jumps On Upbeat Results, iGATE Drops
- Ego Alert: Jamie Dimon Makes His Biggest Mistake
- CONSOL Energy and Other Energy Stocks Worth a Look Now
- Three Surprising Sources of Global ETF Yield
- JP Morgan Declares $0.30/Share Qtr. Dividend, Offers Results of Prelim. Votes at Annual Holders Meeting
- UPDATE: J.P. Morgan Raises PT on Comerica on Improved Economic Data
- iPad 5 Production to Rise in July After Spring Trial
- Microsoft's Third Xbox to be Unveiled in 24 Hours
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- The 8 Possible Changes Tumblr Users Can Expect from the Yahoo Acquisition
- Powerful Breakout May Be Setting Up in Molycorp
- Websense Signs Definitive Agreement to be Acquired by Vista Equity Partners; Shareholders to Receive $24.75 per Share in Cash in Transaction Valued at Approximately $1 Billion
- UPDATE: Bank of America Raises PT on Tesla Motors Following Equity Offering Completion
- MacBook Orders Could Rise, But Shipments May Not
- UPDATE: Nomura Downgrades SanDisk Corporation to Neutral as Stock Approaches Target
- Benzinga Market Primer: Tuesday, May 21